Grant✓ Small businesses may apply
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
National Institutes of Health
- Opportunity #
- PAR-24-279
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.846
- Status
- posted
- Posted
- Dec 9, 2024
- Closes
- Nov 2, 2026
- Funding instrument
- Grant
- Category
- Health
- Cost sharing required
- No
Who can apply
- •Native American tribal governments (Federally recognized)
- •Small businesses
- •Independent school districts
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •County governments
- •State governments
- •For profit organizations other than small businesses
- •Private institutions of higher education
- •City or township governments
- •Public housing authorities/Indian housing authorities
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •Special district governments
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Public and State controlled institutions of higher education
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Synopsis
This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review].
The Simplify Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same.
Contact
National Institutes of Health · grantsinfo@nih.gov